Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Vennesla Legesenter AS
AS
Active
Org 913442148
Sentrumsvegen 41, 4700
Vennesla
General medical practice activities
·
NACE 8621
Est. 2014 · 12 years old
30 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Vennesla Legesenter AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
27M
21M
14M
7M
0M
2021: 21M
21M
2021
2022: 18M (-14% vs 2021)
18M
-14%
2022
2023: 20M (+11% vs 2022)
20M
+11%
2023
2024: 22M (+10% vs 2023)
22M
+10%
2024
2025: 22M (0% vs 2024)
22M
0%
2025
EBITDA
NOK millions
3M
2M
0M
-1M
-2M
2021: 2M
2M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: -1M
-1M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
22 379
22 194
19 930
18 178
21 026
Staff expenses
−14 495
−13 586
−12 893
−11 493
−13 128
EBITDA
−526
383
−35
−1
2 264
Depreciation & amort.
−363
−326
−432
−189
−216
EBIT
−890
58
−468
−190
2 048
Net financials
6
10
155
1
2
Profit before tax
−884
67
−313
−190
2 050
Tax
−0
−0
−42
−41
451
Net profit
−884
67
−271
−149
1 599
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 162
4 761
4 779
4 777
5 619
Equity
1 226
2 110
1 982
2 193
2 282
Long-term debt
0
0
0
42
83
Short-term debt
2 937
2 651
2 797
2 542
3 255
Total debt
2 937
2 651
2 797
2 584
3 338
Financial ratios
5-year trend
EBITDA margin
−2,4 %
This company
15,8 %
Market median
This company
Market median
115% below market
2021
2025
Equity ratio
29,4 %
This company
38,2 %
Market median
This company
Market median
23% below market
2021
2025
Return on equity
−72,1 %
This company
18,4 %
Market median
This company
Market median
492% below market
2021
2025
Net profit margin
−4,0 %
This company
8,1 %
Market median
This company
Market median
149% below market
2021
2025
Asset turnover
5,38×
This company
1,12×
Market median
This company
Market median
380% above market
2021
2025
Debt / equity
2,40×
This company
0,62×
Market median
This company
Market median
287% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Vennesla Legesenter AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
